Skip Navigation


Hum. Reprod. Advance Access originally published online on May 20, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
19/7/1530    most recent
deh298v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by García-Velasco, J.A.
Right arrow Articles by Pellicer, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by García-Velasco, J.A.
Right arrow Articles by Pellicer, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 19, No. 7, 1530-1538, July 2004
© 2004 European Society of Human Reproduction and Embryology

Coasting acts through downregulation of VEGF gene expression and protein secretion

J.A. García-Velasco1,2,3, A. Zúñiga1, A. Pacheco1, R. Gómez2, C. Simón2, J. Remohí2 and A. Pellicer2

1 IVI-Madrid, Rey Juan Carlos University, Madrid, Spain and 2 IVI Foundation, Valencia, Spain

3 To whom correspondence should be addressed at: IVI-Madrid, Santiago de Compostela 88, 28035 Madrid, Spain. e-mail: jgvelasco{at}ivi.es

BACKGROUND: This study was conducted to investigate the mechanisms by which coasting may be effective in decreasing the incidence of ovarian hyperstimulation syndrome (OHSS). METHODS: A total of 160 women (patients and oocyte donors) undergoing coasting and 116 controls were included in the study. Serum, follicular fluid and granulosa cells were collected on the day of oocyte retrieval. Vascular endothelial growth factor (VEGF) concentrations were determined using an enzyme-linked immunosorbent assay (ELISA). Real-time PCR was performed to evaluate VEGF gene expression in granulosa cells. Cell death was studied by flow cytometry using annexin V–fluorescein isothiocyanate (FITC) and counterstaining by propidium iodide, and double staining with CD45 monoclonal antibody was performed to distinguish the contamination of apoptotic leukocytes. RESULTS: Follicular cells aspirated from coasted patients showed a ratio in favour of apoptosis, especially in smaller follicles (48 versus 26%, P < 0.05). Follicular fluid determinations confirmed that coasting reduces VEGF protein secretion (1413 versus 3538 pg/ml, P < 0.001) and gene expression (2-fold decrease) in granulosa cells. Follicular fluid VEGF protein levels positively correlated with follicular size (r = 0.594, P = 0.001) and estradiol production (r = 0.558, P = 0.038). Women who underwent coasting showed a comparable IVF cycle outcome; however, a higher cancellation rate was found in cycles that were coasted. CONCLUSIONS: Coasting affects all follicles through apoptosis, especially immature follicles, without affecting oocyte/endometrial quality. The significant decrease found in VEGF expression and secretion explains why coasting is clinically effective in reducing the incidence and severity of OHSS.

Key words: coasting/ovarian hyperstimulation syndrome/VEGF


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
D. Manau, F. Fabregues, J. Penarrubia, M. Creus, F. Carmona, G. Casals, W. Jimenez, and J. Balasch
Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF
Hum. Reprod., March 1, 2007; 22(3): 669 - 675.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Ryzhov, J. L. McCaleb, A. E. Goldstein, I. Biaggioni, and I. Feoktistov
Role of Adenosine Receptors in the Regulation of Angiogenic Factors and Neovascularization in Hypoxia
J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 565 - 572.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Villasante, A. Pacheco, A. Ruiz, A. Pellicer, and J. A. Garcia-Velasco
Vascular Endothelial Cadherin Regulates Vascular Permeability: Implications for Ovarian Hyperstimulation Syndrome
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 314 - 321.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
N. Prapas, Y. Prapas, Y. Panagiotidis, S. Prapa, P. Vanderzwalmen, R. Schoysman, and G. Makedos
GnRH agonist versus GnRH antagonist in oocyte donation cycles: a prospective randomized study
Hum. Reprod., June 1, 2005; 20(6): 1516 - 1520.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
L. C. Ajonuma, F. O. Ajuonuma, and C. L. Chukwu
Coasting acts through downregulation of VEGF gene expression and protein secretion
Hum. Reprod., February 1, 2005; 20(2): 574 - 575.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.